Theranos Start Up Pitch Deck

Theranos Total Available Market: Phase IV Clinical Trials > Phase IV Clinical Market = $39 Billion per year > Number of ongoing trials per year = 600 to 800 > Average Theranos Revenue per trial = $50M > $7,500 "Information Fee" per patient for every four months > Average: 2,000 to 10,000 patients per trial 11011010001011017 010110100010110150 0101101000101101 Confidential & Proprietary 14

View entire presentation